A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
IDEAYA Biosciences
IDEAYA Biosciences
Fondazione del Piemonte per l'Oncologia
Orano Med LLC
UNC Lineberger Comprehensive Cancer Center
AstraZeneca
City of Hope Medical Center
Huazhong University of Science and Technology
Cedars-Sinai Medical Center
A2 Biotherapeutics Inc.
Memorial Sloan Kettering Cancer Center
Daiichi Sankyo
Indiana University
General Oncology, Inc.
DualityBio Inc.
Northern Jiangsu People's Hospital
Northern Jiangsu People's Hospital
Ruijin Hospital
University Health Network, Toronto
Gødstrup Hospital
University Health Network, Toronto
City of Hope Medical Center
Valent Technologies, LLC
Korea University Anam Hospital
Guangzhou University of Traditional Chinese Medicine
Second Life Therapeutics
Tongji Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Hospital del Mar
National Cancer Centre, Singapore
Lyell Immunopharma, Inc.
Bristol-Myers Squibb
University College, London
Puerta de Hierro University Hospital
Peter MacCallum Cancer Centre, Australia
Fudan University
Esperas Pharma Inc.
Tongji Hospital
A2 Biotherapeutics Inc.
Zhejiang University
UMC Utrecht
Fudan University
Wageningen University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
HiberCell, Inc.
Biomea Fusion Inc.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
European Hepatocellular Cancer Liver Transplant Group
UNICANCER
Stanford University